Kirsten A. Kantak Appointed CEO of Biolumina
Ty Curran Promoted to Chairman
NEW YORK, November 3, 2017 — Omnicom Health Group, part of Omnicom (NYSE: OMC), announced today that Kirsten A. Kantak has been appointed CEO of Biolumina, reporting to Ed Wise, CEO of Omnicom Health Group. She succeeds Ty Curran, who has been promoted to chairman.
Most recently, Kantak served as president of Biolumina. She was promoted to president in 2015. Prior to Biolumina, Kantak was at Harrison and Star for 13 years, most recently as senior vice president, global managing director.
“Kirsten helped take Biolumina into the future, cementing it as a fierce competitor in the healthcare space,” said Curran. “She accomplished this through tremendous new business growth as well as a significant focus on culture. I have no doubt the agency will continue to thrive under Kirsten’s strong leadership.”
“Kirsten’s talent-first approach and passion for delivering superior work for clients will take Biolumina to the next stage in its evolution,” said Wise. “I look forward to continuing to watch the agency’s upward trajectory.”
In his role as chairman, Curran will serve in a consultative role to Kantak, and will take on special healthcare projects across Omnicom Health Group. He will report to Dale Adams, chairman and CEO, the DAS Group of Companies. Prior to this role, Curran served as CEO of Biolumina, as well as sister agency Harrison and Star.
“Ty’s leadership took Biolumina on a strong growth path, and he will continue to provide valuable strategic counsel and guidance in his role as chairman,” said Adams.
The changes are effective January 1, 2018.
Biolumina is a full-service, integrated agency delivering omnichannel solutions for the pharmaceutical industry. We thrive on the intellectual challenges posed by high-science brands and build brand experiences that go beyond the rational, using emotional hooks that tap into the heart of the customer to ignite action, change behavior and create brand loyalty. Learn more at http://www.biolumina.com. Biolumina is part of Omnicom Health Group.
About Omnicom Health Group
Omnicom Health Group (www.omnicomhealthgroup.com) is a global collective of communications companies with more than 3,200 dedicated healthcare communications specialists. It provides marketing services to the health and life-science industries through a combination of specialized agencies, customized client solutions, and collaborations with other Omnicom network agencies. Organized around four customer groups—healthcare professionals, patients, payers, and medical, evidence and regulatory stakeholders—Omnicom Health Group serves more than 100 clients in over 55 offices worldwide. Omnicom Health Group is part of the DAS Group of Companies, a division of Omnicom Group Inc.